Skip to main content

Arax Advisory Partners

Position in ABBV — AbbVie Inc.

CIK 1586767 DENVER, CO

Position in ABBV

as of Jun 30, 2026 · filed Aug 10, 2026
Position Value
$41,494,681
+$30,868,773 QoQ
Shares Held
164,897
+237.5% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.48%
of 13F equity value
Holder Rank
#411
of 4,153 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 50% Shared 0% None 50%

Common Shares in ABBV Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Arax Advisory Partners holds $367,571,362 across 18 Drug Manufacturers - General names. ABBV ranks #4 (11.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
4 ABBV
AbbVie Inc.
This page
164,897 $41,494,681

All Filings in ABBV

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $41,494,681 164,897
2026-03-31 $10,625,908 48,857
2025-12-31 $11,435,239 50,047
2025-09-30 $12,560,118 54,246
2025-06-30 $4,645,326 25,026
2025-03-31 $2,548,391 12,163
2024-12-31 $1,802,766 10,145
2024-09-30 $1,475,174 7,470
2024-06-30 $1,197,209 6,980
2024-03-31 $1,057,636 5,808
2023-12-31 $1,263,159 8,151
2023-09-30 $1,273,865 8,546
2023-06-30 $831,013 6,168
2023-03-31 $963,710 6,047
2022-12-31 $941,539 5,826
2022-09-30 $832,504 6,203
2022-06-30 $911,761 5,953
2022-03-31 $1,023,400 6,313
2021-12-31 $853,967 6,307
2021-09-30 $665,881 6,173
2021-06-30 $664,350 5,898
2020-12-31 $489,139 4,565
2020-09-30 $389,863 4,451
2020-06-30 $429,832 4,378
2020-03-31 $343,007 4,502